日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The ADAPT learning cancer treatment system: ARPA-H's initiative to revolutionize cancer therapy

ADAPT学习型癌症治疗系统:ARPA-H旨在革新癌症治疗的计划

Bild, Andrea H; Sangar, Michelle C; McQuerry, Jasmine A; Ideker, Trey; Kopetz, Scott; Carey, Lisa; Nath, Aritro; Marcus, Daniel; Regier, Allison; Rashid, Naim; Barzilay, Regina; Winer, Eric; Salgia, Ravi; Malhotra, Jyoti; Gentles, Andrew; Buetow, Kenneth; Mahmood, Faisal; Markman, David W; Eddy, James A

Chemoresistance in gynecologic cancers: mechanistic insights and emerging platforms to overcome drug failure

妇科肿瘤的化疗耐药性:机制解析及克服药物失败的新兴平台

Garg, Pankaj; Salgia, Ravi; Singhal, Sharad S

RLIP depletion suppresses ovarian cancer growth and metastasis

RLIP 缺失抑制卵巢癌的生长和转移

Krishna, B Madhu; Garg, Pankaj; Horne, David; Kulkarni, Prakash; Salgia, Ravi; Singhal, Sharad S

Durvalumab Plus Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD

Durvalumab联合化疗治疗一线奥希替尼治疗后疾病进展的EGFR突变晚期非小细胞肺癌患者:ORCHARD

Cho, Byoung Chul; Nishio, Makoto; Ahn, Myung-Ju; García-Campelo, Rosario; Ponce, Santiago; Baik, Christina; Salgia, Ravi; Kim, Sang-We; Lee, Jong Seok; Yoshida, Tatsuya; Yu, Helena A; Goldberg, Sarah B; Johannes de Langen, Adrianus; Le, Xiuning; Piotrowska, Zofia; Riess, Jonathan W; Tanaka, Kentaro; Ambrose, Helen; Cosaert, Jan; Fraenkel, Paula G; Tang, Kwan Ho; Lehman, Jonathan M; Smith, Paul; Goldman, Jonathan W

Correction: Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

更正:通过抗体疗法双重靶向HER家族受体克服对西妥昔单抗的获得性耐药

Iida, Mari; Brand, Toni M; Starr, Megan M; Huppert, Evan J; Luthar, Neha; Bahrar, Harsh; Coan, John P; Pearson, Hannah E; Salgia, Ravi; Wheeler, Deric L

Conformational dynamics and multimodal interaction of Paxillin with the focal adhesion targeting domain

Paxillin 与黏着斑靶向域的构象动力学和多模式相互作用

Bhattacharya, Supriyo; He, Yanan; Chen, Yihong; Mohanty, Atish; Grishaev, Alexander; Kulkarni, Prakash; Salgia, Ravi; Orban, John

Current paradigm of EGFR(ins20) in non-small cell lung cancer: A long way forward

非小细胞肺癌中 EGFR(ins20) 的当前范式:前路漫漫

Miyamura, Beatriz Viesser; Mambetsariev, Isa; Fricke, Jeremy; Arias-Romero, Javier; Cadman, Karla; Shrestha, Sagun; Pisick, Evan; Nguyen, Danny; Malhotra, Jyoti; Reyes, Amanda; Salgia, Ravi

The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancer

受体酪氨酸激酶MET作为非小细胞肺癌治疗靶点的作用日益增强

Sattler, Martin; Salgia, Ravi

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment

非小细胞肺癌中BRAF突变的多样性及其对治疗的影响

Lu, Kevin; Shen, John Paul; Lopez-Diaz, Fernando J; Leal, Alessandro; Mambetsariev, Isa; Parikh, Kaushal; Hazim, Antonious; Woodward, Brian D; Madduri, Abhinav; Khurshid, Faisal; Fricke, Jeremy; Velcheti, Vamsidhar; Riess, Jonathan W; Mansfield, Aaron S; Salgia, Ravi; Husain, Hatim

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

癌症临床试验参与者吸烟流行率及其与社会人口学变量的关系

Presant, Cary A; Till, Cathee; Vaidya, Riha; Ashing, Kimlin Tan; Warren, Graham W; Sun, Virginia; Salgia, Ravi; Massarelli, Erminia; Mortimer, Joanne E; Pal, Sumanta; Dorff, Tanya; Amini, Arya; Erhunmwunsee, Loretta; Phillips, Tanyanika; Hershman, Dawn L; Unger, Joseph M